U.S. Department of Health and Human Services
Griffin Rodgers
 

 Contact Info

 
Tel: 301-496-5741
Email: griffinr@extra.niddk.nih.gov
 

 Select Experience

 
  • M.B.A.Johns Hopkins University2005
  • M.D.Brown University1979
  • M.M.Sc.Brown University1979
  • B.Sc.Brown University1976
 

 Related Links

 

    Griffin P. Rodgers, M.D., M.A.C.P.

    Director, Office of the Director​
    Chief, Molecular and Clinical Hematology Branch
    Chief, Molecular and Clinical Hematology BranchMolecular Hematology Section 

    Specialties: Molecular Biology/Biochemistry, Chemistry/Chemical Biology, Genetics/Genomics, Hematology​​​​

    Griffin P. Rodgers, M.D., M.A.C.P

    Chief, Molecular and Clinical Hematology Branch
    Chief, Molecular and Clinical Hematology BranchMolecular Hematology Section
    Director, Office of the Director
    Specialties
    • Chemistry/Chemical Biology
    • Genetics/Genomics
    • Hematology
    • Molecular Biology/Biochemistry

    ​Publications

    A selection of recent and significant publications can be viewed below.

    Publications
    Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, Rodgers GP, Powell JD, Tisdale JF. Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype. JAMA. 2014 Jul 2; 312:48-56. [Full Text/Abstract]
    Zhu J, Chin K, Aerbajinai W, Kumkhaek C, Li H, Rodgers GP. Hydroxyurea-inducible SAR1 gene acts through the Giα/JNK/Jun pathway to regulate γ-globin expression. Blood. 2014 Jun 9. [Full Text/Abstract]
    Fradkin JE, Cowie CC, Hanlon MC, Rodgers GP. Celebrating 30 years of research accomplishments of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes. 2013 Dec; 62:3963-7. [Full Text/Abstract]
    Li H, Rodriguez-Canales J, Liu W, Zhu J, Hanson JC, Pack S, Zhuang Z, Emmert-Buck MR, Rodgers GP. Deletion of the olfactomedin 4 gene is associated with progression of human prostate cancer. Am J Pathol. 2013 Oct; 183:1329-38. [Full Text/Abstract]
    Liu W, Yan M, Sugui JA, Li H, Xu C, Joo J, Kwon-Chung KJ, Coleman WG, Rodgers GP. Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease. J Clin Invest. 2013 Aug 1. [Full Text/Abstract]
    Aerbajinai W, Lee K, Chin K, Rodgers GP. Glia maturation factor-γ negatively modulates TLR4 signaling by facilitating TLR4 endocytic trafficking in macrophages. J Immunol. 2013 Jun 15; 190:6093-103. [Full Text/Abstract]
    Linder BL, Fradkin JE, Rodgers GP. The TODAY study: an NIH perspective on its implications for research. Diabetes Care. 2013 Jun; 36:1775-6. [Full Text/Abstract]
    Kumkhaek C, Aerbajinai W, Liu W, Zhu J, Uchida N, Kurlander R, Hsieh MM, Tisdale JF, Rodgers GP. MASL1 induces erythroid differentiation in human erythropoietin-dependent CD34+ cells through the Raf/MEK/ERK pathway. Blood. 2013 Apr 18; 121:3216-27. [Full Text/Abstract]
    Fradkin JE, Wallace JA, Rodgers GP. Biomedical research: paving a pathway to diabetes prevention. Am J Prev Med. 2013 Apr; 44:S317-23. [Full Text/Abstract]
    Kumkhaek C, Liu W, Rodgers GP. Identification and characterization of novel full-length cDNAs expressed during hematopoietic lineage-specific differentiation of cultured human peripheral blood mononuclear cells. Blood Cells Mol Dis. 2013 Mar; 50:154-5. [Full Text/Abstract]
    Fradkin JE, Rodgers GP. Diabetes research: a perspective from the National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes. 2013 Feb; 62:320-6. [Full Text/Abstract]
    Liu L, Aerbajinai W, Ahmed SM, Rodgers GP, Angers S, Parent CA. Radil controls neutrophil adhesion and motility through β2-integrin activation. Mol Biol Cell. 2012 Dec; 23:4751-65. [Full Text/Abstract]
    Fradkin JE, Roberts BT, Rodgers GP. What's preventing us from preventing type 2 diabetes? N Engl J Med. 2012 Sep 27; 367:1177-9. [Full Text/Abstract]
    Rodgers GP, Collins FS. The next generation of obesity research: no time to waste. JAMA. 2012 Sep 19; 308:1095-6. [Full Text/Abstract]
    Liu W, Yan M, Liu Y, McLeish KR, Coleman WG Jr, Rodgers GP. Olfactomedin 4 inhibits cathepsin C-mediated protease activities, thereby modulating neutrophil killing of Staphylococcus aureus and Escherichia coli in mice. J Immunol. 2012 Sep 1; 189:2460-7. [Full Text/Abstract]
    Aneja S, Ross JS, Wang Y, Matsumoto M, Rodgers GP, Bernheim SM, Rathore SS, Krumholz HM. US cardiologist workforce from 1995 to 2007: modest growth, lasting geographic maldistribution especially in rural areas. Health Aff (Millwood). 2011 Dec; 30:2301-9. [Full Text/Abstract]
    Aerbajinai W, Liu L, Chin K, Zhu J, Parent CA, Rodgers GP. Glia maturation factor-γ mediates neutrophil chemotaxis. J Leukoc Biol. 2011 Sep; 90:529-38. [Full Text/Abstract]
    Chen L, Li H, Liu W, Zhu J, Zhao X, Wright E, Cao L, Ding I, Rodgers GP. Olfactomedin 4 suppresses prostate cancer cell growth and metastasis via negative interaction with cathepsin D and SDF-1. Carcinogenesis. 2011 Jul; 32:986-94. [Full Text/Abstract]
    Zhu J, Chin K, Aerbajinai W, Trainor C, Gao P, Rodgers GP. Recombinant erythroid Kruppel-like factor fused to GATA1 up-regulates delta- and gamma-globin expression in erythroid cells. Blood. 2011 Mar 17; 117:3045-52. [Full Text/Abstract]
    Brindis R, Rodgers GP, Handberg EM. President's page: team-based care: a solution for our health care delivery challenges. J Am Coll Cardiol. 2011 Mar; 57:1123-5. [Full Text/Abstract]
    Liu W, Lee HW, Liu Y, Wang R, Rodgers GP. Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis. Blood. 2010 Dec 2; 116:4938-47. [Full Text/Abstract]
    Liu W, Yan M, Liu Y, Wang R, Li C, Deng C, Singh A, Coleman WG Jr, Rodgers GP. Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection. Proc Natl Acad Sci U S A. 2010 Jun 15; 107:11056-61. [Full Text/Abstract]
    Hsieh MM, Tisdale JF, Rodgers GP, Young NS, Trimble EL, Little RF. Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy? J Clin Oncol. 2010 Apr 1; 28:1633-7. [Full Text/Abstract]
    Oetgen WJ, Parikh PD, Cacchione JG, Casale PN, Dove JT, Harold JG, Hindle BL, Maglaras M, Rodgers GP, Wright JS. Characteristics of medical professional liability claims in patients with cardiovascular diseases. Am J Cardiol. ; 105:745-52. [Full Text/Abstract]
    Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, Childs RW, Rodgers GP, Powell JD, Tisdale JF. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med. 2009 Dec 10; 361:2309-17. [Full Text/Abstract]
    Bairey Merz CN, Alberts MJ, Balady GJ, Ballantyne CM, Berra K, Black HR, Blumenthal RS, Davidson MH, Fazio SB, Ferdinand KC, Fine LJ, Fonseca V, Franklin BA, McBride PE, Mensah GA, Merli GJ, O'Gara PT, Thompson PD, Underberg JA, American College of Cardiology Foundation, American Heart Association, American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease), American Academy of Neurology, American Association of Cardiovascular and Pulmonary Rehabilitation, American College of Preventive Medicine, American Diabetes Association, American Society of Hypertension, Association of Black Cardiologists, National Lipid Association, Preventive Cardiovascular Nurses Association. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2009 Sep 29; 54:1336-63. [Full Text/Abstract]
    Rodgers GP, Conti JB, Feinstein JA, Griffin BP, Kennett JD, Shah S, Walsh MN, Williams ES, Williams JL. ACC 2009 survey results and recommendations: Addressing the cardiology workforce crisis A report of the ACC board of trustees workforce task force. J Am Coll Cardiol. 2009 Sep 22; 54:1195-208. [Full Text/Abstract]
    Aerbajinai W, Zhu J, Kumkhaek C, Chin K, Rodgers GP. SCF induces gamma-globin gene expression by regulating downstream transcription factor COUP-TFII. Blood. 2009 Jul 2; 114:187-94. [Full Text/Abstract]
    Doo EC, Hoofnagle JH, Rodgers GP. NIH consensus development conference: management of Hepatitis B. Introduction. Hepatology. 2009 May; 49:S1-3. [Full Text/Abstract]
    Vichinsky E, Rodgers GP, Rachmilewitz E. Hemoglobinopathies. Curr Mol Med. 2008 Nov; 8:591. [Full Text/Abstract]